Lizheng Shi
Tulane University
262 Papers
601 Citations
Lizheng Shi is an academic researcher from Tulane University. The author has contributed to research in topics: Medicine & Diabetes mellitus. The author has an hindex of 33, co-authored 208 publications. Previous affiliations of Lizheng Shi include Eli Lilly and Company & Philippine Institute for Development Studies.
Chat about Author
Papers
A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder
TL;DR: How open access affected patient compliance and the likelihood of switching antidepressant therapies is documents and the significant changes in the characteristics of the patient population in response to open access (access effect) complicate attempts to measure the impact of open access on treatment patterns.
27
Biopsy frequency and complications among lung cancer patients in the United States.
TL;DR: Nearly half (46%) of patients in this population of patients diagnosed and treated for primary lung cancer experienced multiple biopsies prior to diagnosis, and biopsy choice or sequence in patients receiving multiple procedures was unpredictable.
25
Outcomes associated with warfarin time in therapeutic range among US veterans with nonvalvular atrial fibrillation.
Shuqian Liu,Xiaoyan Li,Qian Shi,Melissa Hamilton,Keith Friend,Yingnan Zhao,Ruslan Horblyuk,Shalini Hede,Lizheng Shi +8 more
TL;DR: The observed quality of warfarin control in VA EMR suggests room for improvement given the association with elevated risk of adverse clinical outcomes, as well as all-cause mortality.
23
Economic burden of hypoglycemia: utilization of emergency department and outpatient services in the United States (2005-2009)
TL;DR: In this paper, the authors analyzed the National Hospital Ambulatory Medical Care Survey (NHAMCS), including emergency department (ED) and outpatient department (OPD) components, and estimated the rates of injury and ambulance use incurring within a visit for hypoglycemia.
22
Impact of thiazolidinedione safety warnings on medication use patterns and glycemic control among veterans with diabetes mellitus
TL;DR: Thiazolidinedione safety warnings may have negatively impacted the glycemic control in DM patients, and three use pattern groups had similar changes with regard to blood pressure and low-density lipoprotein.
22